A phase II study of clofarabine and daunorubicin in patients age 60 or older with newly diagnosed adult acute myeloid leukemia.
Carlos Enrique Vigil
Research Funding - Genzyme
Elizabeth A. Griffiths
No relevant relationships to disclose
James E Thompson
No relevant relationships to disclose
Wei Tan
No relevant relationships to disclose
Jessica Greene
No relevant relationships to disclose
Laurie Ann Ford
No relevant relationships to disclose
Eunice S. Wang
No relevant relationships to disclose
Meir Wetzler
Research Funding - Genzyme